Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 9Terminated 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Pain 1Neoplasms 1Lung Neoplasms 1Hot Flashes 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Has results × Gabapentin × Clear all
NCT01067144 2022-05-05

Stanford Accelerated Recovery Trial (START)

Stanford University

Phase 3 Terminated
422 enrolled 12 charts
BreastThoracic

Breast Neoplasms, Lung Neoplasms, Pain

NCT03682367 2021-07-09

Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery

University of California, Davis

Phase 3 Terminated
8 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms

NCT01533753 2019-11-21

Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer

University of Wisconsin, Madison

Phase 2 Terminated
5 enrolled 5 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡